ADC Therapeutics SA (ADCT) is a publicly traded Healthcare sector company. As of October 29, 2026, ADCT trades at $1.64 with a market cap of $202.99M and a P/E ratio of -2.98. ADCT moved +0.93% today. Year to date, ADCT is -53.98%; over the trailing twelve months it is -63.43%. Its 52-week range spans $0.78 to $4.98. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces ADCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover ADCT: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $3.50.
| Metric | Value |
|---|---|
| Price | $1.64 |
| Market Cap | $202.99M |
| P/E Ratio | -2.98 |
| EPS | $-0.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.98 |
| 52-Week Low | $0.78 |
| Volume | 1.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $79.58M |
| Net Income | $-96.91M |
| Gross Margin | 0.00% |
2 analysts cover ADCT: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.